Form 4: Keros Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Esther Cho, Chief Legal Officer of Keros Therapeutics, Inc., sold 4,485 shares of common stock on August 18, 2026 for $10.29 per share.
Summary
- Open-market sale: disposed of 4,485 Common Stock at $10.29 ($46,151) on August 18, 2026; holds 35,770 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $46,151 of stock on the open market.
Insider Transactions
Esther Cho — Officer (Chief Legal Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Open-market sale | Common Stock | 4,485 | $10 | $46.2K | 35,770 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Open-market sale (4,485 shares) |
Keywords
insider transaction, Form 4, KROS, Keros Therapeutics, Inc., bearish, Esther Cho
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.